Metropolitan Life Insurance CO Kempharm, Inc Transaction History

Metropolitan Life Insurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	N/A	-920 Reduced 48.09%	993 $4,000
Q2 2023 Aug 10, 2023	BUY	$4.94 - $6.29 $9,450 - $12,032	1,913 New	1,913 $9,000
Q4 2021 Feb 15, 2022	SELL	$7.6 - $10.26 $27,344 - $36,915	-3,598 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$8.72 - $13.31 $31,374 - $47,889	3,598 New	3,598 $33,000
Q3 2021 Mar 30, 2023	SELL	$8.72 - $13.31 $46,067 - $70,316	-5,283 Reduced 59.49%	3,598 $33,000
Q3 2021 Nov 15, 2021	SELL	$8.72 - $13.31 $46,067 - $70,316	-5,283 Reduced 59.49%	3,598 $34,000
Q2 2021 Jun 21, 2023	BUY	$8.52 - $15.47 $75,666 - $137,389	8,881 New	8,881 $113,000
Q2 2021 Mar 30, 2023	BUY	$8.52 - $15.47 $75,666 - $137,389	8,881 New	8,881 $113,000
Q2 2021 Aug 16, 2021	BUY	$8.52 - $15.47 $75,666 - $137,389	8,881 New	8,881 $114,000

117

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.